What changed in this filing

/stocks — the workspaceLOADING

Item 7. Management’s Discussion and Analysis

2025-03-27 compared with 2024-03-28 · 33 added, 28 removed, 226 unchanged (21% of the section changed)

113 unchanged sentences

Results of Operations

For the Year Ended December 31, 2023 Compared

to December 31, 2022

For the years ended December

31, 2023 and 2022, revenues were $177,570 and $114,288, respectively, with an increase of $63,282 over the same period in 2022.

was due to the Company’s increase efforts to attract technology development services from client since the fiscal year beginning2023.

Technology development revenue increased in $37,369 in fiscal year 2023 compared with fiscal year 2022 as Universe Travel acquired three

new clients which are Shenzhen Eryuechuer Culture & Technology., Ltd, Shenzhen Shangjia Electronic Technology., Ltd and Shenzhen Zhongke

Hengjin Technology Co., Ltd

For the Year Ended December 31, 2024 Compared to December 31, 2023

For the years ended December 31, 2024 and 2023, revenues were $97,394

and $177,570, respectively, with a decrease of $80,176 over the same period in 2023.

The decrease in revenue was mainly due to the Company

not providing technology development service to the Company’s clients for the year ended December 31, 2024.

From January to December

31, 2023, Universe Travel provided technology development services to its three major clients, Shenzhen Eryuechuer Culture & Technology.,

Ltd, Shenzhen Shangjia Electronic Technology., Ltd and Shenzhen Zhongke Hengjin Technology Co., Ltd, which generated $95,082 in revenue

for the Company during the year ended December 31, 2023.

Cost of Revenue

Cost of Revenue for the years ended December 31, 2024 and 2023 were

$96,107 and $77,043, respectively, with an increase of $19,064 over the same period in 2022.

The increase of cost was mainly due to the

increase of technology and development revenue of Universe Travel, thus the cost of revenue increased accordingly.

$55,473 and $96,107, respectively, with a decrease of $40,634 over the same period in 2023.

The decrease was mainly due to the decrease

of revenue, thus the cost of revenue also decreased accordingly.

Gross profits were $41,921 and $81,463 for the years ended December

31, 2023 and 2022, respectively, an increase of $44,218 over the same period in 2022.

31, 2024 and 2023, respectively, a decrease of $39,542 over the same period in 2023.

The gross profit ratios were 43.0% and 45.9% for

the years ended December 31, 2024 and 2023, respectively.

The increase of gross profit ratio due to technology development service revenue

increased in 2023, which have a higher gross profit.

The slight decrease of gross profit margin for the year ended December 31, 2024

compared to the same period of 2023 was due to the fact that the Company’s technology development services accounted for lower proportion

of revenue for the year ended December 31, 2024.

Technology development services have a higher gross profit margin, thus the gross profit

margin decreased compared to the same period last year.

Operating Expenses

1 unchanged sentence

$204,957 and $229,301, respectively, with a decrease of $24,344 or 10.6% from the same period in 2023.

The decrease was mainly due to

lower service fees from OTC listings and other consulting services.

The decrease of operating expenses

was mainly due to decrease of service fees paid for other consulting services as compared to the prior period.

Other Income (Expenses)

Other income consists of interest income and exchange

For the year ended December 31, 2023, the net other expense were $683 compared with net income of $1,514 for the same period

The change of other income (expenses) mainly due to the change of exchange rate.

Other income consists of interest income and exchange gain (loss).

For the year ended December 31, 2024 and 2023, the net other expense were $1,038 and $683.

The change of other income (expenses) mainly

due to the change of exchange rate.

Net Losses for the years ended December 31, 2024

and 2023 were $155,074 and $148,521, respectively, due to the reasons described above.

Liquidity and Capital Resources

11 unchanged sentences

terms and there can be no assurance that any additional funding that we do obtain will be sufficient to meet our needs in the long term.

Net cash used in operating

activities for the year ended December 31, 2023 amounted to $152,949, compared to $321,340 net cash used in operating activities for

the year ended December 31, 2022.

cash used in operating activities for the year ended December 31, 2024 amounted to $ 148,977, compared to $152,949 net cash used

in operating activities for the year ended December 31, 2023.

Net cash used in operating activities mostly consist of net loss.

The net loss for year ended December

31, 2023 and 2022 were $148,521 and $284,028, respectively.

Net cash provided by financing activities for the year ended December

31, 2023 amounted to $129,676, compared to $78,045 for the same period in 2022.

The net cash provided by financing activities were from

shareholders who paid cost and other expenses on behalf of the Company.

loss for year ended December 31, 2024 and 2023 were $155,074 and $148,521, respectively.

Net cash provided by financing activities for

the year ended December 31, 2024 amounted to $136,523, compared to $129,676 for the same period in 2023.

The net cash provided by financing

activities were from shareholders who paid cost and other expenses on behalf of the Company.

Going Concern

88 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-K

Item 7. Management’s Discussion and Analysis